← Leaderboards
Timothy Fouts
Advanced Bioscience Laboratories, Inc.
$52,990,932
Attributed
$52,990,932
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $18.2M · FY2018–25$20M$15M$10M$5M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$52,990,932 · 3
By mechanism
N01$52,990,932 · 3
Top collaborators
No co-investigators on record.
Most similar at Advanced Bioscience Laboratories, Inc.
Same institution · by research overlap
- Thomas Vancott$47,641,448
- Phillip Ishikawa$23,550,479
- John Mascola$10,873,727
Others in their field
Other Emerging Leaders on “National Institute Of Allergy And Infectious Disease”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Beth Baseler · Leidos Biomedical Research, Inc.$158,999,256
- Kimberly Smith · Ppd Development Lp$122,921,392
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$72,037,072
- Ted Ross · University Of Georgia$71,962,304
Research focus
National Institute Of Allergy And Infectious DiseaseResearch Clinical TestingPreclinical DevelopmentDocumentationInvestigational DrugsPreclinical TestingProductionContractsHiv VaccineImmunogenicityProtocols DocumentationContractorHiv-1Clinical TrialsProteinsVaccinesProduct DevelopmentFlexibilityInvestigator-Initiated ResearchResearch StudyIn VitroAntigensPlasmid DnaEfficacy Study
Grant awards (53)
Production of cGMP Native Flexibly Linked HIV-1 Envelope Protein$185,516
N01 · FY2025 · AI · contact PI
Next Generation Development of Broadly Neutralizing HIV Antibodies for Prevention$180,640
N01 · FY2025 · AI · contact PI
Production of a Chimpanzee Adenovirus HIV-1 Vaccine$83,673
N01 · FY2025 · AI · contact PI
NIAID PRECLINICAL DEVELOPMENT SUPPORT - Production of Clade B, B.63521Î11 gp120 Env Protein$46,812
N01 · FY2025 · AI · contact PI
NIAID Preclinical Development Support - Production of a HIV gp145 Clade C Trimer Protein$25,135
N01 · FY2025 · AI · contact PI
cGMP Manufacturing of Monoclonal Antibodies (mAbs) Against HIV$3,349,931
N01 · FY2024 · AI · contact PI
cGMP Manufacturing of Glycopeptide Immunogen Nanoparticle Vaccine$523,084
N01 · FY2024 · AI · contact PI
cGMP Manufacture, Fill-Finish, Release, and Stability Testing of a Nanoparticle Based HIV Envelope Containing Vaccine$479,043
N01 · FY2024 · AI · contact PI
Production of a Chimpanzee Adenovirus HIV-1 Vaccine$331,050
N01 · FY2024 · AI · contact PI
Next Generation Development of Broadly Neutralizing HIV Antibodies for Prevention$326,373
N01 · FY2024 · AI · contact PI
NIAID Preclinical Development Support: Essential Core Activities$154,735
N01 · FY2024 · AI · contact PI
NIAID Preclinical Development Support: Essential Core Activities$73,907
N01 · FY2024 · AI · contact PI
cGMP Manufacturing of Monoclonal Antibodies (mAbs) Against HIV$15,396,723
N01 · FY2023 · AI · contact PI
cGMP Manufacture, Fill-Finish, Release, and Stability Testing of a Nanoparticle Based HIV Envelope Containing Vaccine$1,619,441
N01 · FY2023 · AI · contact PI
NIAID Preclinical Development Support: Essential Core Activities$649,452
N01 · FY2023 · AI · contact PI
Production of cGMP Native Flexibly Linked HIV-1 Envelope Protein$335,921
N01 · FY2023 · AI · contact PI
Next Generation Development of Broadly Neutralizing HIV Antibodies for Prevention$182,226
N01 · FY2023 · AI · contact PI
NIAID Preclinical Development Support - Production of HIV-1 M Group Conserved Element DNAs$23,741
N01 · FY2023 · AI · contact PI
NIAID Preclinical Development Support: Essential Core Activities$818,424
N01 · FY2022 · AI · contact PI
cGMP Manufacture, Fill-Finish, Release, and Stability Testing of a Nanoparticle Based HIV Envelope Containing Vaccine$423,033
N01 · FY2022 · AI · contact PI
NIAID Preclinical Development Support - Production of a HIV gp145 Clade C Trimer Protein$254,278
N01 · FY2022 · AI · contact PI
Fill-Finish, Release, and Stability Testing of HIV-1 gp120 Proteins$191,043
N01 · FY2022 · AI · contact PI
cGMP Production of HIV-1 Envelope (Env) Bulk Harvest$154,198
N01 · FY2022 · AI · contact PI
Production of a Chimpanzee Adenovirus HIV-1 Vaccine$115,569
N01 · FY2022 · AI · contact PI
NIAID Preclinical Development Support: Essential Core Activities$105,254
N01 · FY2022 · AI · contact PI
NIAID PRECLINICAL DEVELOPMENT SUPPORT - Production of Clade B, B.63521Î11 gp120 Env Protein$84,531
N01 · FY2022 · AI · contact PI
NIAID Preclinical Development Support: Essential Core Activities$33,045
N01 · FY2022 · AI · contact PI
Transcriptomics of RhCMV/SIV Vector-Vaccinated Macaques$27,042
N01 · FY2022 · AI · contact PI
cGMP Manufacture, Fill-Finish, Release, and Stability Testing of a Nanoparticle Based HIV Envelope Containing Vaccine$4,199,938
N01 · FY2021 · AI · contact PI
NIAID Preclinical Development Support: Essential Core Activities$1,912,456
N01 · FY2021 · AI · contact PI
Production of eCD4-IG protein$955,917
N01 · FY2021 · AI · contact PI
Next Generation Development of Broadly Neutralizing HIV Antibodies for Prevention$741,241
N01 · FY2021 · AI · contact PI
Production of cGMP Native Flexibly Linked HIV-1 Envelope Protein$403,922
N01 · FY2021 · AI · contact PI
NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF MHRP GP145 CLADE C PROTEIN$118,368
N01 · FY2021 · AI · contact PI
NIAID PRECLINICAL DEVELOPMENT SUPPORT - Production of Clade B, B.63521Î11 gp120 Env Protein$84,106
N01 · FY2021 · AI · contact PI
NIAID Preclinical Development Support - Production of GEO-D02 DNA Drug Product$19,531
N01 · FY2021 · AI · contact PI
cGMP Manufacturing of Glycopeptide Immunogen Nanoparticle Vaccine$1,949,201
N01 · FY2020 · AI · contact PI
NIAID PRECLINICAL DEVELOPMENT SUPPORT: Essential Core Activities$1,866,402
N01 · FY2020 · AI · contact PI
Procurement of cGMP QS21 and Production of cGMP ALF55 Drug Substance$1,782,227
N01 · FY2020 · AI · contact PI
Fill-Finish, Release, and Stability Testing of HIV-1 gp120 Proteins$524,564
N01 · FY2020 · AI · contact PI
Next Generation Development of Broadly Neutralizing HIV Antibodies for Prevention$470,027
N01 · FY2020 · AI · contact PI
NIAID Preclinical Development Support: Essential Core Activities$394,216
N01 · FY2020 · AI · contact PI
NIAID Preclinical Development Support - Production of HIV-1 M Group Conserved Element DNAs$151,691
N01 · FY2020 · AI · contact PI
NIAID Preclinical Development Support - Production of HIV-gp120 Proteins$124,332
N01 · FY2020 · AI · contact PI
NIAID Preclinical Development Support - Production of a HIV gp145 Clade C Trimer Protein$92,245
N01 · FY2020 · AI · contact PI
NIAID PRECLINICAL DEVELOPMENT SUPPORT - Production of Clade B, B.63521Î11 gp120 Env Protein$79,856
N01 · FY2020 · AI · contact PI
NIAID Preclinical Development Support - HIV-1 Envelope Protein Production$66,657
N01 · FY2020 · AI · contact PI
NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF GEO-D02 DNA DRUG PRODUCT$56,401
N01 · FY2020 · AI · contact PI
Transcriptomics of RhCMV/SIV Vector-Vaccinated Macaques$13,763
N01 · FY2020 · AI · contact PI
cGMP Production of a HCMV gag (P4) prototype HIV vaccine candidate$5,496,857
N01 · FY2019 · AI · contact PI
cGMP Manufacturing of Glycopeptide Immunogen Nanoparticle Vaccine$3,150,138
N01 · FY2019 · AI · contact PI
Task V06: Process development and manufacture of cGMP compliant parvovirus B19 vaccine drug product for use in Phase I/II clinical trials$2,093,700
N01 · FY2019 · AI · contact PI
Vaccine Manufacturing and Characterization Services$69,356
N01 · FY2018 · AI · contact PI